Vertex Pharmaceuticals (VRTX) Gross Profit Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 411.41% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 7.16% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 4.34% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 51.16% |
| 10 | Revolution Medicines | 30.42 Bn | 30.42 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.16% |
| Dec 31, 2025 | 10.49% |
| Sep 30, 2025 | 9.18% |
| Jun 30, 2025 | 9.75% |
| Mar 31, 2025 | 9.14% |
| Dec 31, 2024 | 10.89% |
| Sep 30, 2024 | 10.83% |
| Jun 30, 2024 | 13.25% |
| Mar 31, 2024 | 15.30% |
| Dec 31, 2023 | 14.70% |
| Sep 30, 2023 | 16.99% |
| Jun 30, 2023 | 17.70% |
| Mar 31, 2023 | 15.94% |
| Dec 31, 2022 | 314.33% |
| Sep 30, 2022 | 35.72% |
| Jun 30, 2022 | 33.91% |
| Mar 31, 2022 | 34.36% |
| Dec 31, 2021 | 34.64% |
| Sep 30, 2021 | 37.43% |
| Jun 30, 2021 | 34.19% |
| Mar 31, 2021 | 39.10% |
| Dec 31, 2020 | 35.90% |
| Sep 30, 2020 | 38.83% |
| Jun 30, 2020 | 41.50% |
| Mar 31, 2020 | 26.53% |
| Dec 31, 2019 | -27.51% |
| Sep 30, 2019 | 31.90% |
| Jun 30, 2019 | 28.29% |
| Mar 31, 2019 | 29.90% |
| Dec 31, 2018 | 29.49% |
| Sep 30, 2018 | 35.23% |
| Jun 30, 2018 | 62.61% |
| Mar 31, 2018 | 67.33% |
| Dec 31, 2017 | 62.10% |
| Sep 30, 2017 | 58.50% |
| Jun 30, 2017 | 61.31% |
| Mar 31, 2017 | 82.49% |
| Dec 31, 2016 | 51.16% |
| Sep 30, 2016 | 20.91% |
| Jun 30, 2016 | 18.36% |